M

MacroGenics, Inc.

393 employees

MacroGenics is a biotechnology company developing immunotherapeutics to prevent autoimmune disorders, cancer and infectious diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Fc Optimization
Infectious Diseases
Oncology
Medical
Monoclonal Antibodies
Manufacturing
Autoimmune Disorders
Bi-Specific Antibodies

Date founded

2000

Funding rounds raised

Total raised

$45M

from 33 investors over 33 rounds

M

MacroGenics, Inc. raised $9.8M on July 15, 2010

Investors: National Institutes of Health

M

MacroGenics, Inc. raised $25M on October 23, 2008

Investors: RiverVest Venture Partners, Nextech Venture, Bank of Tokyo-Mitsubishi UFJ, Ventures West, TPG Global, OrbiMed Advisors and InterWest Partners

M

MacroGenics, Inc. raised $13M on July 29, 2008

Investors: Clarus Ventures, LLC, Alta Partners, InterWest Partners and TPG Global

M

MacroGenics, Inc. raised $45M on May 17, 2006

Investors: RiverVest Venture Partners, Caisse de dépôt et placement du Québec (CDPQ), Biogen Idec, TPG Global, OrbiMed Advisors, MPM Capital, Ventures West and Alta Partners

M

MacroGenics, Inc. raised $31M on October 15, 2004

Investors: Vivo Capital, TPG Global, MPM Capital, Alta Partners, OrbiMed Advisors and InterWest Partners

M

MacroGenics, Inc. raised $13M on June 7, 2002

Investors: MPM Capital, OrbiMed Advisors, STARTech Early Ventures and InterWest Partners

M

MacroGenics, Inc. raised $14M on September 25, 2001

Investors: InterWest Partners, MPM Capital and OrbiMed Advisors

FAQ